Company Analysis

Inhibrx Biosciences, Inc. (INBX)

Nasdaq: INBX · Biological Products, (No Diagnostic Substances) · La Jolla, CA · filing with the SEC since 2024
Grade4.5
◀ Past 5.2● Present 4.2▶ Future 4.4
2 est.

Who runs Inhibrx Biosciences, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Lappe Mark
Chief Executive Officer. First filing May 2024, latest Oct 14, 2026, 7 filings in all.
Officers reporting now
2
of 6 people with a filing in the last fifteen months
Directors reporting now
4
8 people on the record since 2024
Officerssales are open-market, Oct 14, 2025 to Oct 14, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Lappe MarkChief Executive OfficerMay 2024Oct 14, 2026none
Matly DavidPresidentApr 2025Apr 27, 2026none
Directorssales are open-market, Oct 14, 2025 to Oct 14, 2026
NameRoleFirst filingLatest filingSales, 12 months
Kayyem Jon FaizdirectorMay 2024Sep 23, 2026none
Forsyth DouglasdirectorMay 2024Sep 18, 2026none
Manhard KimberlydirectorMay 2024Sep 18, 20265 · $300,000
Vuori Kristiina MddirectorMay 2024Sep 18, 2026none
Owners of more than 10% of a classsales are open-market, Oct 14, 2025 to Oct 14, 2026
NameRoleFirst filingLatest filingSales, 12 months
Halvorsen Ole Andreas10% ownerJun 2024Oct 9, 2025none
Ott David C.10% ownerJun 2024Oct 9, 2025none
Shabet Rose Sharon10% ownerJun 2024Oct 9, 2025none
Viking Global Investors LP10% ownerJun 2024Oct 9, 2025none
Viking Global Opportunities Gp LLC10% ownerJun 2024Oct 9, 2025none
Viking Global Opportunities Illiquid Investments Sub-Master LP10% ownerJun 2024Oct 9, 2025none
Viking Global Opportunities Parent Gp LLC10% ownerJun 2024Oct 9, 2025none
Viking Global Opportunities Portfolio Gp LLC10% ownerJun 2024Oct 9, 2025none
Earlier names on the record3, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton INBX · research, not advice